tiprankstipranks
AIM ImmunoTech Inc (AIM)
:AIM
US Market

AIM ImmunoTech (AIM) Income Statement

Compare
879 Followers

AIM ImmunoTech Income Statement

Last quarter (Q3 2024), AIM ImmunoTech's total revenue was $35.00K, a decrease of -23.91% from the same quarter last year. In Q3, AIM ImmunoTech's net income was $-3.70M. See AIM ImmunoTech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 202.00K$ 141.00K$ 135.00K$ 163.00K$ 140.00K
Gross Profit
$ 160.00K$ -19.78M$ -715.00K$ -643.00K$ -753.00K
Operating Expenses
$ 32.08M$ 20.06M$ 16.34M$ 14.37M$ 11.69M
Depreciation and Amortization
$ 238.00K$ -424.00K$ 805.00K$ 706.00K$ 829.00K
EBITDA
$ -31.68M$ -19.87M$ -18.25M$ -13.02M$ -8.15M
Operating Income
$ -31.92M$ -19.92M$ -18.84M$ -15.15M$ -12.44M
Other Income/Expenses
$ 2.95M$ 478.00K$ -289.00K$ 752.00K$ 3.04M
Pretax Income
$ -28.96M$ -19.45M$ -19.13M$ -14.40M$ -9.53M
Net Income
$ -28.96M$ -21.09M$ -21.51M$ -16.26M$ -10.83M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.60$ -0.44$ -0.45$ -0.51$ -2.97
Diluted EPS
$ -0.60$ -0.44$ -0.45$ -0.51$ -2.97
Weighted Average Shares Outstanding
48.59M 48.05M 47.34M 31.84M 3.64M
Weighted Average Shares Outstanding (Diluted)
48.59M 48.05M 47.34M 31.84M 3.64M
Currency in USD

AIM ImmunoTech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis